Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-MMSCs for COVID-19 Pneumonia
NCT04461925Phase 2Unknown
- Sponsor
- Institute of Cell Therapy
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of placenta-derived multipotent mesenchymal stromal cells in COVID-19 pneumonia, sponsored by Institute of Cell Therapy. Status: unknown.
02
Drugs
placenta-derived multipotent mesenchymal stromal cells
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04461925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04461925.